von Felden, J <br/><br/>
Editorial: genotype 3 HCV-who still needs ribavirin in a pan-genotypic era? Authors' reply.  [electronic resource] 

 -  Alimentary pharmacology & therapeutics  06 2018 
 - 1550-1551 p.  digital 
<br/><br/> Publication Type: Editorial; Research Support, Non-U.S. Gov't; Comment 
<br/><br/><label>ISSN: </label>1365-2036 
<br/><br/><label>Standard No.: </label>10.1111/apt.14648  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Carbamates<br/>Genotype<br/>Hepacivirus<br/>Hepatitis C<br/>Heterocyclic Compounds, 4 or More Rings<br/>Humans<br/>Ribavirin<br/>Sofosbuvir